NovaBridge Biosciences (FRA:0VY) Forward Dividend Yield %: 0.00% (As of Jul. 02, 2026)


FRA:0VY NovaBridge Biosciences FRA:0VY
24 GF Score
Price €1.68
! 2 Warning Signs
View Full Analysis

What is NovaBridge Biosciences Forward Dividend Yield %?

NovaBridge Biosciences FRA:0VY -1.75% 24 Forward Dividend Yield % is 0.00% as of Jul. 02, 2026. GuruFocus rates FRA:0VY with a GF Score™ of 24/100. The stock has 2 warning signs investors should review. Among 147 Biotechnology companies, NovaBridge Biosciences ranks worse than 680271.43% on this metric.

As of today (2026-07-02), the Forward Annual Dividend Yield of NovaBridge Biosciences is 0.00%.

As of today (2026-07-02), the Trailing Annual Dividend Yield of NovaBridge Biosciences is 0.00%.

FRA:0VY's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.53
* Ranked among companies with meaningful Forward Dividend Yield % only.

NovaBridge Biosciences's Dividends per Share for the three months ended in Dec. 2025 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

NovaBridge Biosciences  (FRA:0VY) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

NovaBridge Biosciences Forward Dividend Yield % Related Terms

FRA:0VY vs HUMA, DTIL, ORMP: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, NovaBridge Biosciences's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NovaBridge Biosciences Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NovaBridge Biosciences's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where NovaBridge Biosciences's Forward Dividend Yield % falls into.


FRA:0VY
24GF Score
NovaBridge Biosciences FRA:0VY
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NovaBridge Biosciences Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
NovaBridge Biosciences (FRA:0VY) has a Forward Dividend Yield % of 0.00% as of Jul. 02, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on NovaBridge Biosciences and its competitors. According to the industry distribution chart, NovaBridge Biosciences ranks #999999 out of 147 companies in the Biotechnology industry.
Is NovaBridge Biosciences' Forward Dividend Yield % too high?
NovaBridge Biosciences' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, NovaBridge Biosciences ranks #999999 out of 147 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, NovaBridge Biosciences has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does NovaBridge Biosciences' Forward Dividend Yield % compare to HUMA and DTIL?
According to the Biotechnology industry distribution chart, NovaBridge Biosciences ranks #999999 out of 147 companies for Forward Dividend Yield %. This places NovaBridge Biosciences in the lower half of its industry. The industry median Forward Dividend Yield % is 1.53. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.53, based on 147 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on NovaBridge Biosciences and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NovaBridge Biosciences's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NovaBridge Biosciences stock overvalued right now?
NovaBridge Biosciences (FRA:0VY) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. NovaBridge Biosciences' overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For NovaBridge Biosciences (FRA:0VY), the current Forward Dividend Yield % is 0.00% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NovaBridge Biosciences Business Description

Other Exchanges NBP:USA
Address 2440 Research Boulevard, Suite 400, Rockville, MD, USA, 20850
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
24GF Score

Get the complete analysis for FRA:0VY

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.68
Price